Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis

Summary

To evaluate the efficacy of SR-T100 gel by observing the lesion size (length x width x height) of human cutaneous squamous cell carcinoma in situ (Actinic Keratosis and Bowen's Disease) reduced at least 75%.

Timeline

Start

2007-11

Primary completion

2010-04

Completion

2010-11

Drugs

Indications